These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30817986)

  • 1. Efficacy of budesonide-loaded mesoporous silica microparticles capped with a bulky azo derivative in rats with TNBS-induced colitis.
    Ferri D; Costero AM; Gaviña P; Parra M; Merino V; Teruel AH; Sancenón F; Martínez-Máñez R
    Int J Pharm; 2019 Apr; 561():93-101. PubMed ID: 30817986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double Drug Delivery Using Capped Mesoporous Silica Microparticles for the Effective Treatment of Inflammatory Bowel Disease.
    Teruel AH; Pérez-Esteve É; González-Álvarez I; González-Álvarez M; Costero AM; Ferri D; Gaviña P; Merino V; Martínez-Máñez R; Sancenón F
    Mol Pharm; 2019 Jun; 16(6):2418-2429. PubMed ID: 30991003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smart gated magnetic silica mesoporous particles for targeted colon drug delivery: New approaches for inflammatory bowel diseases treatment.
    Teruel AH; Pérez-Esteve É; González-Álvarez I; González-Álvarez M; Costero AM; Ferri D; Parra M; Gaviña P; Merino V; Martínez-Mañez R; Sancenón F
    J Control Release; 2018 Jul; 281():58-69. PubMed ID: 29753956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioefficacy of budesonide loaded crosslinked polyelectrolyte microparticles in rat model of induced colitis.
    Crcarevska MS; Dodov MG; Petrusevska G; Gjorgoski I; Goracinova K
    J Drug Target; 2009 Dec; 17(10):788-802. PubMed ID: 19938950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats.
    Mura C; Nácher A; Merino V; Merino-Sanjuan M; Carda C; Ruiz A; Manconi M; Loy G; Fadda AM; Diez-Sales O
    Int J Pharm; 2011 Sep; 416(1):145-54. PubMed ID: 21723929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colon-specific delivery of budesonide with azopolymer-coated pellets: therapeutic effects of budesonide with a novel dosage form against 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats.
    Tozaki H; Fujita T; Komoike J; Kim SI; Terashima H; Muranishi S; Okabe S; Yamamoto A
    J Pharm Pharmacol; 1999 Mar; 51(3):257-61. PubMed ID: 10344625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced therapeutic effect of LK-423 in treating experimentally induced colitis in rats when administered in colon delivery microcapsules.
    Smrdel P; Cerne M; Bogataj M; Urleb U; Mrhar A
    J Microencapsul; 2010; 27(7):572-82. PubMed ID: 20690794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the macrolide antibacterial drug, tylosin, on TNBS-induced colitis in the rat.
    Menozzi A; Pozzoli C; Poli E; Lazzaretti M; Cantoni A; Grandi D; Giovannini E; Coruzzi G
    Pharmacology; 2005 Jun; 74(3):135-42. PubMed ID: 15756055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesoporous silica microparticles gated with a bulky azo derivative for the controlled release of dyes/drugs in colon.
    Ferri D; Gaviña P; Parra M; Costero AM; El Haskouri J; Amorós P; Merino V; Teruel AH; Sancenón F; Martínez-Máñez R
    R Soc Open Sci; 2018 Aug; 5(8):180873. PubMed ID: 30225077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model.
    Makhlof A; Tozuka Y; Takeuchi H
    Eur J Pharm Biopharm; 2009 May; 72(1):1-8. PubMed ID: 19348015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats.
    Dhaneshwar SS; Gairola N; Kandpal M; Vadnerkar G; Bhatt L
    Bioorg Med Chem; 2007 Jul; 15(14):4903-9. PubMed ID: 17499512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colon-specific delivery of budesonide from microencapsulated cellulosic cores: evaluation of the efficacy against colonic inflammation in rats.
    Rodriguez M; Antúnez JA; Taboada C; Seijo B; Torres D
    J Pharm Pharmacol; 2001 Sep; 53(9):1207-15. PubMed ID: 11578103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budesonide-Loaded Eudragit S 100 Nanocapsules for the Treatment of Acetic Acid-Induced Colitis in Animal Model.
    Qelliny MR; Aly UF; Elgarhy OH; Khaled KA
    AAPS PharmSciTech; 2019 Jun; 20(6):237. PubMed ID: 31243601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and in vitro/in vivo evaluation of dextran matrix tablets of budesonide in experimental ulcerative colitis in rats.
    Ahmadi F; Varshosaz J; Emami J; Tavakoli N; Minaiyan M; Mahzouni P; Dorkoosh F
    Drug Deliv; 2011 Feb; 18(2):122-30. PubMed ID: 20954795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced therapeutic efficacy of budesonide in experimental colitis with enzyme/pH dual-sensitive polymeric nanoparticles.
    Naeem M; Cao J; Choi M; Kim WS; Moon HR; Lee BL; Kim MS; Jung Y; Yoo JW
    Int J Nanomedicine; 2015; 10():4565-80. PubMed ID: 26213469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy.
    Karrout Y; Dubuquoy L; Piveteau C; Siepmann F; Moussa E; Wils D; Beghyn T; Neut C; Flament MP; Guerin-Deremaux L; Dubreuil L; Deprez B; Desreumaux P; Siepmann J
    J Control Release; 2015 Jan; 197():121-30. PubMed ID: 25445696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Magnetic Mesoporous Silica Microparticles Capped with an Azo-Derivative: A Promising Colon Drug Delivery Device.
    Teruel AH; Coll C; Costero AM; Ferri D; Parra M; Gaviña P; González-Álvarez M; Merino V; Marcos MD; Martínez-Máñez R; Sancenón F
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29439396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and toxicity of Eudragit-coated chitosan-succinyl-prednisolone conjugate microspheres using rats with 2,4,6-trinitrobenzenesulfonic acid-induced colitis.
    Onishi H; Oosegi T; Machida Y
    Int J Pharm; 2008 Jun; 358(1-2):296-302. PubMed ID: 18394832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Nanoparticle Morphology on Enhancing Delivery of Budesonide for Treatment of Inflammatory Bowel Disease.
    Li Q; Liu W; Liu K; Dong Z; Kong W; Lu X; Wei Y; Wu W; Yang J; Qi J
    ACS Appl Mater Interfaces; 2024 Jul; 16(26):33081-33092. PubMed ID: 38888094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of budesonide-succinate-dextran conjugate as a novel prodrug of budesonide against acetic acid-induced colitis in rats.
    Varshosaz J; Emami J; Fassihi A; Tavakoli N; Minaiyan M; Ahmadi F; Mahzouni P; Dorkoosh F
    Int J Colorectal Dis; 2010 Oct; 25(10):1159-65. PubMed ID: 20669022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.